Otwarty dostęp

Early Diagnosing and Treatment of Rheumatoid Arthritis, Benefits of Anti-Citrullinated Peptides Examination


Zacytuj

1. van Steenberger HW, Ajeganova S, Forslind K, Swensson B, van der Helm-van Mil AHM. The Effect of Rheumatoid Factor and Anticitrullinated Peptide Antibodies on Bone Erosions in Rheumatoid Arthritis. Ann Rheum Dis 2015; e3: 74.10.1136/annrheumdis-2014-206623Search in Google Scholar

2. Britsemmer K, Ursum J, Gerritsen M, van Tuyl L, van Schaardenburg D. Validation of the 2010 ACR/EULAR Criteria for Rheumatoid Arthritis: Slight Improvement Over 1987 ACR Criteria. Ann Rheum Dis 2011; 70(8): 1468-70.10.1136/ard.2010.148619Search in Google Scholar

3. Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Hejde D. Treating Rheumatoid Arthritis to Target: Recommendations of an International Task Force. Ann Rheum Dis 2010; 69(4): 631-7.10.1136/ard.2009.123919Search in Google Scholar

4. Kaneko Y, Kuwana M, Kameda H, Takeuchi T. Sensitivity and Specificity of 2010 Rheumatoid Arthritis Classification Criteria. Rheumatology(Oxford) 2011; 50(7): 1268-74.10.1093/rheumatology/keq442Search in Google Scholar

5. Willemze A, Trouw LA, Toes RE, Huizinga TW. The Influence of ACPA Status and Characteristics on the Course of RA. Nat Rev Rheumatol 2012; 8(3): 144-52.10.1038/nrrheum.2011.204Search in Google Scholar

eISSN:
1335-8421
Język:
Angielski
Częstotliwość wydawania:
3 razy w roku
Dziedziny czasopisma:
Medicine, Clinical Medicine, Internal Medicine, Cardiology